ACOR - Acorda Therapeutics Inc. (ACOR) CEO Ron Cohen on Q4 2019 Results - Earnings Call Transcript
Acorda Therapeutics, Inc. (ACOR)
Q4 2019 Earnings Conference Call
February 13, 2020 8:30 A.M. ET
Company Participants
Tierney Saccavino - Executive Vice President, Corporate Communications
Ron Cohen - Chief Executive Officer
Conference Call Participants
Michael Yee - Jefferies
Presentation
Operator
Welcome to the Acorda Therapeutics, Fourth Quarter 2019 Update. At this time, all participants are in listen-only mode. There will be a question-and-answer session to follow. Please be advised that this call is being taped at the company’s request.
I will now introduce your host for today, Tierney Saccavino, Executive Vice President, Corporate Communications at